Ustékinumab (Sterala®), l'axe Th17-IL23 du psoriasis et au-delà.

FRANCHIMONT, Claudine; Hermanns-Lê, Trinh; QUATRESOOZ, Pascale; PIERARD, Gérald

Request a copy

Article (Scientific journals)

Ustékinumab (Sterala®), l'axe Th17-IL23 du psoriasis et au-delà.

FRANCHIMONT, Claudine; Hermanns-Lê, Trinh; QUATRESOOZ, Pascale et al.

2012 • In Dermatologie Actualité, 131, p. 28-30

Permalink
https://hdl.handle.net/2268/125889

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

USTEKINUMAB.pdf

Publisher postprint (1.06 MB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Dermatology

Author, co-author :

FRANCHIMONT, Claudine ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Hermanns-Lê, Trinh ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

QUATRESOOZ, Pascale ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

PIERARD, Gérald ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Language :

French

Title :

Ustékinumab (Sterala®), l'axe Th17-IL23 du psoriasis et au-delà.

Alternative titles :

[nl] Ustekinumab (Stelara®), de as Th17-IL23 van psoriasis en meer.

Publication date :

2012

Journal title :

Dermatologie Actualité

ISSN :

1780-4957

Publisher :

Soprest, Bruxelles, Belgium

Volume :

131

Pages :

28-30

Available on ORBi :

since 22 June 2012

Statistics

Number of views

115 (7 by ULiège)

Number of downloads

2 (1 by ULiège)

More statistics